Ameriprise
IBDX icon

Ameriprise’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Ameriprise’s Portfolio IBDX Stock Details IBDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.5M Sell
1,009,242
-773,096
-43% -$19.7M 0.01% 1254
2025
Q4 		$45.3M Buy
1,782,338
+74,744
+4% +$1.91M 0.01% 933
2025
Q3 		$43.8M Buy
1,707,594
+899,251
+111% +$22.8M 0.01% 966
2025
Q2 		$20.2M Buy
808,343
+171,517
+27% +$4.26M 0.01% 1346
2025
Q1 		$15.9M Buy
636,826
+38,584
+6% +$954K ﹤0.01% 1457
2024
Q4 		$14.7M Buy
598,242
+556,331
+1,327% +$13.9M ﹤0.01% 1535
2024
Q3 		$1.08M Buy
41,911
+12,514
+43% +$316K ﹤0.01% 3191
2024
Q2 		$722K Buy
29,397
+9,037
+44% +$221K ﹤0.01% 3301
2024
Q1 		$505K Buy
+20,360
New +$504K ﹤0.01% 3409

Other funds holding IBDX

ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.22B AUM 22.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
SIC
Sigma Investment Counselors Northville, Michigan $1.89B AUM 14.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KA
Klingman & Associates New York $2.09B AUM 16.49% 1-Year Est. Return